Want to create an interactive transcript for this episode?
Podcast: Science Quickly
Episode: Your Next Pain Prescription Could Come without Addiction Risk
Description: The Food and Drug Administration has granted priority review to suzetrigine, a novel painkiller. It’s part of a new class of medications that could provide relief to those with chronic pain. The drugs target sodium channels on nerve cells, stopping pain signaling at the periphery. Journalist Marla Broadfoot explains the biology of aches and pains and the reasons it is so challenging to develop well-tolerated medications for pain.Recommended reading:New Painkiller Could Bring Relief to Millions—Without Addiction Risk Ozempic Quiets Food Noise in the Brain—But How? E-m...